Entrance Pharmaceuticals & Research Center is a leading Ghanaian pharmaceutical manufacturing and research company based in Accra, Greater Accra Region, Ghana. It is the manufacturing subsidiary of Tobinco Group of Companies, commissioned in 2014 to strengthen local pharmaceutical production and research capacity in the region.

The company is dedicated to producing high‑quality, essential medicines that meet both national and international standards, including oral liquids, tablets, capsules, topical preparations, and beta‑lactam and non‑beta‑lactam formulations. These products support treatment needs for conditions such as malaria, HIV/AIDS, and other essential health conditions, and are manufactured in compliance with Good Manufacturing Practice (GMP) guidelines under oversight by the Ghana Food and Drugs Authority (FDA).

In addition to manufacturing, Entrance Pharmaceuticals incorporates a research centre in collaboration with academic partners like the University of Ghana School of Pharmacy to advance pharmaceutical research, product development, and quality improvement initiatives. This research focus helps the company innovate and adapt to evolving health‑care needs.

Entrance Pharmaceuticals has achieved ISO 9001:2015 certification, reflecting its commitment to quality, safety, and continuous improvement, and has been recognized with multiple industry awards, including accolades at the Ghana Manufacturing Awards for excellence in manufacturing, corporate social responsibility, and health and safety.

The company’s mission is to meet the pharmaceutical needs of Ghana and the sub‑region by delivering safe, effective, and affordable medicines, and its vision is to become a premium provider of quality pharmaceutical products across Africa and beyond.